1. Home
  2. ELAN vs CRNX Comparison

ELAN vs CRNX Comparison

Compare ELAN & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELAN
  • CRNX
  • Stock Information
  • Founded
  • ELAN 1954
  • CRNX 2008
  • Country
  • ELAN United States
  • CRNX United States
  • Employees
  • ELAN N/A
  • CRNX N/A
  • Industry
  • ELAN Biotechnology: Pharmaceutical Preparations
  • CRNX Biotechnology: Pharmaceutical Preparations
  • Sector
  • ELAN Health Care
  • CRNX Health Care
  • Exchange
  • ELAN Nasdaq
  • CRNX Nasdaq
  • Market Cap
  • ELAN 6.3B
  • CRNX 5.3B
  • IPO Year
  • ELAN 2018
  • CRNX 2018
  • Fundamental
  • Price
  • ELAN $14.04
  • CRNX $54.59
  • Analyst Decision
  • ELAN Buy
  • CRNX Strong Buy
  • Analyst Count
  • ELAN 6
  • CRNX 10
  • Target Price
  • ELAN $17.00
  • CRNX $73.70
  • AVG Volume (30 Days)
  • ELAN 4.7M
  • CRNX 623.8K
  • Earning Date
  • ELAN 11-07-2024
  • CRNX 11-12-2024
  • Dividend Yield
  • ELAN N/A
  • CRNX N/A
  • EPS Growth
  • ELAN N/A
  • CRNX N/A
  • EPS
  • ELAN 0.41
  • CRNX N/A
  • Revenue
  • ELAN $4,454,000,000.00
  • CRNX $1,038,999.00
  • Revenue This Year
  • ELAN $2.22
  • CRNX N/A
  • Revenue Next Year
  • ELAN $2.77
  • CRNX $494.25
  • P/E Ratio
  • ELAN $34.22
  • CRNX N/A
  • Revenue Growth
  • ELAN 1.99
  • CRNX N/A
  • 52 Week Low
  • ELAN $11.20
  • CRNX $27.55
  • 52 Week High
  • ELAN $18.80
  • CRNX $62.53
  • Technical
  • Relative Strength Index (RSI)
  • ELAN 53.55
  • CRNX 56.15
  • Support Level
  • ELAN $12.35
  • CRNX $58.17
  • Resistance Level
  • ELAN $14.71
  • CRNX $62.53
  • Average True Range (ATR)
  • ELAN 0.47
  • CRNX 2.17
  • MACD
  • ELAN 0.18
  • CRNX -0.08
  • Stochastic Oscillator
  • ELAN 60.21
  • CRNX 53.59

About ELAN Elanco Animal Health Incorporated

Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.

About CRNX Crinetics Pharmaceuticals Inc.

Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors.

Share on Social Networks: